FDA Approved: ICATIBANT — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for ICATIBANT submitted by Fresenius Kabi USA, LLC, finalizing changes to the product as described in the supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ICATIBANT (icatibant)

Snippet

SUPPL AP for ICATIBANT (ICATIBANT)